Cefoxitin

   
Google
 
Web NewDrugInformation.com

Cefoxitin


Drug - Cefoxitin
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Cefoxitin Sodium
Multiple ingredients are in alphabetical order.

Strength - EQ 10GM BASE/VIAL
The potency of the active ingredient(s), Cefoxitin Sodium. May repeat for multiple part products.

Applicant - BAXTER HLTHCARE
The firm name holding legal responsibility for Cefoxitin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 065050
The FDA assigned number to Cefoxitin. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Cefoxitin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Sep 11, 2000
The date Cefoxitin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Cefoxitin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Cefoxitin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Baxter Healthcare Corp Anesthesia And Critical Care
The full name of the firm holding legal responsibility for the new application of Cefoxitin.

Cefoxitin